IOVANCE BIOTHERAPEUTICS, INC.

IOVA

Form 4 • Statement of Changes in Beneficial Ownership

SEC Accession Number: 0001104659-26-023539
Filing date: Mar 4, 2026
Earliest execution date: Mar 2, 2026
Reporting Owners: Vogt Frederick G (CEO)

Summary

Type

Sell

Net shares

-22,809

% of shares

-4.42%

Amount (USD)

$86,446

Insider confidence score

42.5 out of 100

Positive

  • Tax withholding obligation

Negative

  • Large tax withholding sell (≥1% of shares)
  • Significant sell amount ($50K+)

Stock transactions

Transaction 1

Security

Common Stock

Action

Exercise

Date

2026-03-02

Code

M

Net shares

+52,087.0

Acquired/Disposed

Acquired

Shares Owned Before

464,522.0

Shares Owned After

516,609.0

Transaction 2

Security

Common Stock

Action

Tax_withhold

Date

2026-03-02

Code

F

Net shares

-22,809.0

Price per Share

$3.79

Amount (USD)

$86,446.11

Acquired/Disposed

Disposed

Shares Owned Before

516,609.0

Shares Owned After

493,800.0

Derivative Transactions

Transaction 1

Security

Restricted Stock Units

Action

Exercise

Date

2026-03-02

Code

M

Net shares

-41,669.0

Acquired/Disposed

Disposed

Shares Owned Before

208,344.0

Shares Owned After

166,675.0

Transaction 2

Security

Restricted Stock Units

Action

Exercise

Date

2026-03-02

Code

M

Net shares

-10,418.0

Acquired/Disposed

Disposed

Shares Owned Before

10,418.0

Shares Owned After

0.0

Filing's footnotes

1. Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date.

2. Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities.

3. Represents common stock remaining after deducting the common stock withheld for taxes.

4. Each RSU represents a contingent right to receive one share of the Issuer's common stock.

5. The remaining RSUs will vest in equal quarterly installments.

6. Such aggregate number reflects the remainder of such RSUs granted on March 1, 2024, but does not include any other RSUs held by such Reporting Person.

7. Such aggregate number reflects the remainder of such RSUs granted on March 2, 2023, but does not include any other RSUs held by such Reporting Person.

This page is for informational purposes only. While we strive for accuracy, the summary may contain inaccuracies or omissions. Please refer to the official SEC filing for authoritative information. Open the SEC filing.